Home » Topics » BioWorld Science

BioWorld Science
RSS

Customization of regulatory elements in hearing loss gene therapies using AAVAnc80 vectors

Feb. 10, 2022

Challenge Bioproducts synthesizes new PTGER4 ligands

Feb. 10, 2022

Reaction Biology presents new HDAC inhibitors

Feb. 10, 2022

Eccogene divulges new GLP-1R agonists

Feb. 10, 2022

Chinese researchers identify new CRBN modulators

Feb. 10, 2022

Anti-VISTA HMBD-002 antibody blocks VISTA-induced immunosuppression in preclinical models

Feb. 10, 2022

Researchers improve cisplatin-induced ototoxicity model

Feb. 10, 2022

TMID enzymes as potential antiviral targets for the treatment of HHV infections

Feb. 10, 2022

New drug combinations with synergistic inhibitory activity against SARS-CoV-2

Feb. 9, 2022

For pain signaling, endocytosis is not the end

Feb. 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...